GUIDE TO GOOD MANUFACTURING PRACTICE …
Introduction PE 009-8 (Intro) - 3 - 15 January 2009 15 January 2002 PH 1/97 (Rev. 3) New Annex 4 New Annex 5 Reference to Annex 18 of EC GMP
Tags:
Guide, Good, Practices, Manufacturing, Guide to good manufacturing practice
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Current Global GMP Status and Trends With Focus …
www.jpma.or.jpCurrent Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing. Stephan Rönninger Pharma Medicines Technical Operations Global Quality & Compliance , F. Hoffmann-La Roche Ltd
Global, Trends, Current, Status, Current global gmp status and trends
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comPE 0092 dated - 1 July 2004 published by the Pharmaceutical Inspection Cooperation Scheme (PIC/S). The modifications to that Guide and its adoption as the South African Guide to Good Manufacturing Practice is done so with the expressed permission of the PIC/S.
Good, Practices, Control, Manufacturing, Medicine, Council, Medicines control council, Good manufacturing practice
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comImplementation. 1997 . Version 1 . Chapter 9 (Validation) reformatted : January 2004. Version 2 . Adoption of PIC/S GMP Guide of July 2004 : January 2006
PIC/S GMPガイドに沿った 医薬品品質システム
www.toyama-kusuri.jp1 よりよい医薬品づくりを⽀援する「GMP Platform」 2015/03/17 GMP Seminar @ Toyama Pharmaceutical Association ® PIC/S GMPガイドに沿った 医薬品品質システム
Examples of critical and major observations from …
www.unicef.orgExamples of critical and major observations from GMP inspections of Manufacturing, QC and Contract Research Organisations Prequalification Programme: Priority …
Form, Critical, Major, Observation, Of critical and major observations from, Of critical and major observations from gmp
GUIDE TO GOOD MANUFACTURING PRACTICE …
www.medsafe.govt.nzpharmaceutical inspection convention pharmaceutical inspection co-operation scheme pe 009-8 (part ii) 15 january 2009 pe 009-8 (part ii) 15 january 2009
Guide, Good, Practices, Manufacturing, Guide to good manufacturing practice
PIC/S GMP Annex 8全梱包確認試験の課題と事例
www.jpma.or.jpアステラス ファーマ テック株式会社. GMP. 企画室 木村 弘二. PIC/S GMP Annex 8全梱包確認試験の課題と事例
対訳資料：PIC/S(EU) GMP Annex 1 Draft
www.ph-s.com参考資料 EU-GMP Annex -1 改定案 1 / 121 頁 訳文には誤訳、誤謬、タイプミスがあります。訳文は目安ですので、判断と行動は必ず原文によって行って下さい。